Thierry Dervieux's Email & Phone

Dr Thierry Dervieux has nearly 20 years experience with the development of cutting edge drug monitoring and molecular diagnostic assays in partnership with academia and diagnostic industry. Prior to joining Exagen, Dr Dervieux was Vice President of Research and Development with Cypress Bioscience where he developed Exagen's current portfolio in the rheumatology space. He was also Principal Scientist and director of research at Prometheus Laboratories prior to joining Proprius Pharmaceuticals (acquired by Cypress Bioscience in 2008). Dr Dervieux is board certified by the American Board of Clinical Chemistry and holds certificate of qualification as medical laboratory director in the categories of clinical chemistry, drug monitoring, genetic testing, diagnostic immunology and molecular oncology. Dr Dervieux has authored over 50 publications, abstracts and book chapters, and is the inventor on multiple patents and patent applications in the field of personalized medicine and companion diagnostics. Dr Dervieux holds PharmD and PhD degrees from Claude Bernard University (Lyon, France), a degree in biostatistics from the University of Pierre et Marie Curie (Paris, France), and trained at St Jude Children's Research Hospital (Memphis, TN).